Amended Termination of Registration of a Class of Security Under Section 12(b) (15-12b/a)
March 18 2020 - 9:14AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15/A
Amendment No. 1
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission File Number 001-31368
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Approximate number of holders of record as of the certification or notice date: Zero (0).
Pursuant to the requirements of the Securities Exchange Act of 1934, Sanofi. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Explanatory Note: This Amendment No. 1 to Form 15 (this “Amendment No. 1”) amends and restates the Form 15 filed by Sanofi (the “Company”) on March 16, 2020. The purpose of this Amendment No. 1 is to clarify that the Company’s duty to file reports
under Sections 13(a) and 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) remains.
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
From Apr 2023 to Apr 2024